Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 186

1.

Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis.

Rong LQ, Hameed I, Salemi A, Rahouma M, Khan FM, Wijeysundera HC, Angiolillo DJ, Shore-Lesserson L, Biondi-Zoccai G, Girardi LN, Fremes SE, Gaudino M.

J Am Heart Assoc. 2019 Oct;8(19):e013463. doi: 10.1161/JAHA.119.013463. Epub 2019 Sep 24.

2.

Transcatheter Aortic Valve Replacement With the HLT Meridian Valve.

Rodés-Cabau J, Williams MR, Wijeysundera HC, Kereiakes DJ, Paradis JM, Staniloae C, Saric M, Radhakrishnan S, Wilson RF, Kubo SH.

Circ Cardiovasc Interv. 2019 Aug;12(8):e008053. doi: 10.1161/CIRCINTERVENTIONS.119.008053. Epub 2019 Jul 31.

PMID:
31362540
3.

Surgical valve selection in the era of transcatheter aortic valve replacement in the Society of Thoracic Surgeons Database.

Tam DY, Rocha RV, Wijeysundera HC, Austin PC, Dvir D, Fremes SE.

J Thorac Cardiovasc Surg. 2019 Jun 17. pii: S0022-5223(19)31207-3. doi: 10.1016/j.jtcvs.2019.05.081. [Epub ahead of print]

PMID:
31350026
4.

Outcomes Following Transcatheter Aortic Valve Replacement for Degenerative Stentless Versus Stented Bioprostheses.

Duncan A, Moat N, Simonato M, de Weger A, Kempfert J, Eggebrecht H, Walton A, Hellig F, Kornowski R, Spargias K, Mendiz O, Makkar R, Guerrero M, Rihal C, George I, Don C, Iadanza A, Bapat V, Welsh R, Wijeysundera HC, Wood D, Sathananthan J, Danenberg H, Maisano F, Garcia S, Gafoor S, Nombela-Franco L, Cobiella J, Dvir D.

JACC Cardiovasc Interv. 2019 Jul 8;12(13):1256-1263. doi: 10.1016/j.jcin.2019.02.036. Epub 2019 Jun 12.

PMID:
31202944
5.

Imaging of Aortic Valve Cusps Using Commissural Alignment: Guidance for Transcatheter Leaflet Laceration With BASILICA.

Komatsu I, Leipsic J, Webb JB, Blanke P, Mackensen GB, Don CW, McCabe JM, Rumer C, Tan CW, Levin DB, Ramos M, Aldea GS, Reisman M, Wijeysundera HC, Radhakrishnan S, Sathananthan J, Piazza N, Kornowski R, Dvir D.

JACC Cardiovasc Imaging. 2019 Jun 8. pii: S1936-878X(19)30453-X. doi: 10.1016/j.jcmg.2019.04.019. [Epub ahead of print] No abstract available.

PMID:
31202758
6.

The value of screening for cognition, depression, and frailty in patients referred for TAVI.

Khan MM, Lanctôt KL, Fremes SE, Wijeysundera HC, Radhakrishnan S, Gallagher D, Gandell D, Brenkel MC, Hazan EL, Docteur NG, Herrmann N.

Clin Interv Aging. 2019 May 8;14:841-848. doi: 10.2147/CIA.S201615. eCollection 2019.

7.

Profiling Hospital Performance on the Basis of Readmission After Transcatheter Aortic Valve Replacement in Ontario, Canada.

Elbaz-Greener G, Qiu F, Webb JG, Henning KA, Ko DT, Czarnecki A, Roifman I, Austin PC, Wijeysundera HC.

J Am Heart Assoc. 2019 Jun 18;8(12):e012355. doi: 10.1161/JAHA.119.012355. Epub 2019 Jun 5.

8.

Outcomes matter but processes may matter more in valve procurement.

Tam DY, Wijeysundera HC, Fremes SE.

J Thorac Cardiovasc Surg. 2019 Apr;157(4):e201-e202. doi: 10.1016/j.jtcvs.2018.10.105. No abstract available.

PMID:
30901808
9.

The Vancouver 3M (Multidisciplinary, Multimodality, But Minimalist) Clinical Pathway Facilitates Safe Next-Day Discharge Home at Low-, Medium-, and High-Volume Transfemoral Transcatheter Aortic Valve Replacement Centers: The 3M TAVR Study.

Wood DA, Lauck SB, Cairns JA, Humphries KH, Cook R, Welsh R, Leipsic J, Genereux P, Moss R, Jue J, Blanke P, Cheung A, Ye J, Dvir D, Umedaly H, Klein R, Rondi K, Poulter R, Stub D, Barbanti M, Fahmy P, Htun N, Murdoch D, Prakash R, Barker M, Nickel K, Thakkar J, Sathananthan J, Tyrell B, Al-Qoofi F, Velianou JL, Natarajan MK, Wijeysundera HC, Radhakrishnan S, Horlick E, Osten M, Buller C, Peterson M, Asgar A, Palisaitis D, Masson JB, Kodali S, Nazif T, Thourani V, Babaliaros VC, Cohen DJ, Park JE, Leon MB, Webb JG.

JACC Cardiovasc Interv. 2019 Mar 11;12(5):459-469. doi: 10.1016/j.jcin.2018.12.020.

PMID:
30846085
10.

Comparison of Readmission and Death Among Patients With Cardiac Disease in Northern vs Southern Ontario.

Donio PJ, Freitas C, Austin PC, Ross HJ, Abdel-Qadir HM, Wijeysundera HC, Tu K, Cram P, Liu P, Abrams H, Udell JA, Mak S, Farkouh ME, Tu JV, Wang X, Tobe SW, Lee DS.

Can J Cardiol. 2019 Mar;35(3):341-351. doi: 10.1016/j.cjca.2019.01.004.

PMID:
30825954
11.

The predictors and economic burden of early-, mid- and late-onset cardiac implantable electronic device infections: a retrospective cohort study in Ontario, Canada.

Daneman N, Homenauth E, Saskin R, Ng R, Ha A, Wijeysundera HC.

Clin Microbiol Infect. 2019 Feb 22. pii: S1198-743X(19)30056-4. doi: 10.1016/j.cmi.2019.02.009. [Epub ahead of print]

PMID:
30797886
12.

Corrigendum to 'The Ross procedure versus mechanical aortic valve replacement in young patients: a decision analysis' [Eur J Cardiothorac Surg 2019;55:1180--6].

Tam DY, Wijeysundera HC, Ouzounian M, Fremes SE.

Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1241. doi: 10.1093/ejcts/ezz018. No abstract available.

PMID:
30778559
13.

Variation in Revascularization Practice and Outcomes in Asymptomatic Stable Ischemic Heart Disease.

Czarnecki A, Qiu F, Elbaz-Greener G, Cohen EA, Ko DT, Roifman I, Wijeysundera HC.

JACC Cardiovasc Interv. 2019 Feb 11;12(3):232-241. doi: 10.1016/j.jcin.2018.10.049. Epub 2019 Jan 16.

PMID:
30660456
14.

Association between transitional care factors and hospital readmission after transcatheter aortic valve replacement: a retrospective observational cohort study.

Czarnecki A, Austin PC, Fremes SE, Tu JV, Wijeysundera HC, Ko DT.

BMC Cardiovasc Disord. 2019 Jan 18;19(1):23. doi: 10.1186/s12872-019-1003-9.

15.

Association of Clinical and Economic Outcomes With Permanent Pacemaker Implantation After Transcatheter Aortic Valve Replacement.

Aljabbary T, Qiu F, Masih S, Fang J, Elbaz-Greener G, Austin PC, Rodés-Cabau J, Ko DT, Singh S, Wijeysundera HC.

JAMA Netw Open. 2018 May 18;1(1):e180088. doi: 10.1001/jamanetworkopen.2018.0088.

16.

Developing key performance indicators for prescription medication systems.

Spackman E, Clement F, Allan GM, Bell CM, Bjerre LM, Blackburn DF, Blais R, Hazlewood G, Klarenbach S, Nicolle LE, Persaud N, Alessi-Severini S, Tierney M, Wijeysundera HC, Manns B.

PLoS One. 2019 Jan 15;14(1):e0210794. doi: 10.1371/journal.pone.0210794. eCollection 2019.

17.

Association Between Wait Time for Transcatheter Aortic Valve Replacement and Early Postprocedural Outcomes.

Elbaz-Greener G, Yarranton B, Qiu F, Wood DA, Webb JG, Fremes SE, Radhakrishnan S, Wijeysundera HC.

J Am Heart Assoc. 2019 Jan 8;8(1):e010407. doi: 10.1161/JAHA.118.010407.

18.

Eligibility, Clinical Outcomes, and Budget Impact of PCSK9 Inhibitor Adoption: The CANHEART PCSK9 Study.

Ko DT, Khan AM, Kotrri G, Austin PC, Wijeysundera HC, Koh M, Chu A, Jackevicius CA, Lawler PR, Tu JV.

J Am Heart Assoc. 2018 Nov 6;7(21):e010007. doi: 10.1161/JAHA.118.010007.

19.

Profiling Hospital Performance Based on Mortality After Transcatheter Aortic Valve Replacement in Ontario, Canada.

Elbaz-Greener G, Qiu F, Masih S, Fang J, Austin PC, Cantor WJ, Dvir D, Asgar AW, Webb JG, Ko DT, Wijeysundera HC.

Circ Cardiovasc Qual Outcomes. 2018 Dec;11(12):e004947. doi: 10.1161/CIRCOUTCOMES.118.004947.

PMID:
30562064
20.

The Ross procedure versus mechanical aortic valve replacement in young patients: a decision analysis.

Tam DY, Wijeysundera HC, Ouzounian M, Fremes SE.

Eur J Cardiothorac Surg. 2019 Jun 1;55(6):1180-1186. doi: 10.1093/ejcts/ezy414.

PMID:
30535102
21.

Albuminuria, Reduced Kidney Function, and the Risk of ST - and non-ST-segment-elevation myocardial infarction.

de Chickera SN, Bota SE, Kuwornu JP, Wijeysundera HC, Molnar AO, Lam NN, Silver SA, Clark EG, Sood MM.

J Am Heart Assoc. 2018 Oct 16;7(20):e009995. doi: 10.1161/JAHA.118.009995.

22.

Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification.

Yoon SH, Whisenant BK, Bleiziffer S, Delgado V, Dhoble A, Schofer N, Eschenbach L, Bansal E, Murdoch DJ, Ancona M, Schmidt T, Yzeiraj E, Vincent F, Niikura H, Kim WK, Asami M, Unbehaun A, Hirji S, Fujita B, Silaschi M, Tang GHL, Kuwata S, Wong SC, Frangieh AH, Barker CM, Davies JE, Lauten A, Deuschl F, Nombela-Franco L, Rampat R, Nicz PFG, Masson JB, Wijeysundera HC, Sievert H, Blackman DJ, Gutierrez-Ibanes E, Sugiyama D, Chakravarty T, Hildick-Smith D, de Brito FS Jr, Jensen C, Jung C, Smalling RW, Arnold M, Redwood S, Kasel AM, Maisano F, Treede H, Ensminger SM, Kar S, Kaneko T, Pilgrim T, Sorajja P, Van Belle E, Prendergast BD, Bapat V, Modine T, Schofer J, Frerker C, Kempfert J, Attizzani GF, Latib A, Schaefer U, Webb JG, Bax JJ, Makkar RR.

Eur Heart J. 2019 Feb 1;40(5):441-451. doi: 10.1093/eurheartj/ehy590.

PMID:
30357365
23.

Long-Term Outcomes After Transcatheter Aortic Valve-in-Valve Replacement.

de Freitas Campos Guimarães L, Urena M, Wijeysundera HC, Munoz-Garcia A, Serra V, Benitez LM, Auffret V, Cheema AN, Amat-Santos IJ, Fisher Q, Himbert D, Garcia Del Blanco B, Dager A, Le Breton H, Paradis JM, Dumont E, Pibarot P, Rodés-Cabau J.

Circ Cardiovasc Interv. 2018 Sep;11(9):e007038. doi: 10.1161/CIRCINTERVENTIONS.118.007038.

PMID:
30354588
24.

Emergency Department Volume and Outcomes for Patients After Chest Pain Assessment.

Ko DT, Dattani ND, Austin PC, Schull MJ, Ross JS, Wijeysundera HC, Tu JV, Eberg M, Koh M, Krumholz HM.

Circ Cardiovasc Qual Outcomes. 2018 Nov;11(11):e004683. doi: 10.1161/CIRCOUTCOMES.118.004683.

PMID:
30354285
25.

Cost and effectiveness: Can't have one without the other.

Tam DY, Hughes A, Wijeysundera HC, Fremes SE.

J Thorac Cardiovasc Surg. 2018 Nov;156(5):1851-1853. doi: 10.1016/j.jtcvs.2018.05.027. No abstract available.

PMID:
30336914
26.

Validation of billing code combinations to identify cardiovascular magnetic resonance imaging scans in Ontario, Canada: a retrospective cohort study.

Roifman I, Qiu F, Connelly KA, Wright GA, Farkouh M, Jimenez-Juan L, Wijeysundera HC.

BMJ Open. 2018 Oct 8;8(10):e021370. doi: 10.1136/bmjopen-2017-021370.

27.

The state of transcatheter aortic valve implantation training in Canadian cardiac surgery residency programs.

Tam DY, Makhdoum A, Ouzounian M, Wijeysundera HC, Cohen GN, Fremes SE.

Can J Surg. 2018 Dec 1;61(6):418-423. doi: 10.1503/cjs.017517.

28.

Single Versus Dual Lead Atrioventricular Sequential Pacing for Acquired Atrioventricular Block During Transcatheter Aortic Valve Implantation Procedures.

Chan WK, Danon A, Wijeysundera HC, Singh SM.

Am J Cardiol. 2018 Aug 15;122(4):633-637. doi: 10.1016/j.amjcard.2018.04.043. Epub 2018 Jun 20.

PMID:
30205889
29.

Transcatheter valve-in-valve versus redo surgical aortic valve replacement for the treatment of degenerated bioprosthetic aortic valve: A systematic review and meta-analysis.

Tam DY, Vo TX, Wijeysundera HC, Dvir D, Friedrich JO, Fremes SE.

Catheter Cardiovasc Interv. 2018 Dec 1;92(7):1404-1411. doi: 10.1002/ccd.27686. Epub 2018 Jul 19.

PMID:
30024102
30.

Providing high-value care at the right price.

Tam DY, Wijeysundera HC, Fremes SE.

J Thorac Cardiovasc Surg. 2018 Aug;156(2):606-607. doi: 10.1016/j.jtcvs.2018.01.008. No abstract available.

PMID:
30011757
31.

Cardiac computed tomography and magnetic resonance imaging vs. transoesophageal echocardiography for diagnosing left atrial appendage thrombi.

Vira T, Pechlivanoglou P, Connelly K, Wijeysundera HC, Roifman I.

Europace. 2019 Jan 1;21(1):e1-e10. doi: 10.1093/europace/euy142.

PMID:
29961869
32.

Bedside risk score for prediction of acute kidney injury after transcatheter aortic valve replacement.

Zivkovic N, Elbaz-Greener G, Qiu F, Arbel Y, Cheema AN, Dvir D, Fefer P, Finkelstein A, Fremes SE, Radhakrishnan S, Rodés-Cabau J, Shuvy M, Wijeysundera HC.

Open Heart. 2018 May 30;5(1):e000777. doi: 10.1136/openhrt-2018-000777. eCollection 2018.

33.

Trends in the incidence and outcomes of patients with aortic stenosis hospitalization.

Czarnecki A, Qiu F, Koh M, Alter DA, Austin PC, Fremes SE, Tu JV, Wijeysundera HC, Yan AT, Ko DT.

Am Heart J. 2018 May;199:144-149. doi: 10.1016/j.ahj.2018.02.010. Epub 2018 Feb 13.

PMID:
29754653
34.

Cost-Effectiveness of Self-Expandable Transcatheter Aortic Valves in Intermediate-Risk Patients.

Tam DY, Hughes A, Wijeysundera HC, Fremes SE.

Ann Thorac Surg. 2018 Sep;106(3):676-683. doi: 10.1016/j.athoracsur.2018.03.069. Epub 2018 May 3.

PMID:
29730344
35.

Appropriate utilization of cardiac magnetic resonance for the assessment of heart failure and potential associated cost savings.

Kaushal N, Wijeysundera HC, Connelly KA, Roifman I.

J Magn Reson Imaging. 2019 Jun;49(7):e132-e138. doi: 10.1002/jmri.26015. Epub 2018 Mar 23.

PMID:
29573034
36.

Temporal Trends and Clinical Consequences of Wait Times for Transcatheter Aortic Valve Replacement.

Elbaz-Greener G, Masih S, Fang J, Ko DT, Lauck SB, Webb JG, Nallamothu BK, Wijeysundera HC.

Circulation. 2018 Jul 31;138(5):483-493. doi: 10.1161/CIRCULATIONAHA.117.033432.

PMID:
29511000
37.

A cost-utility analysis of transcatheter versus surgical aortic valve replacement for the treatment of aortic stenosis in the population with intermediate surgical risk.

Tam DY, Hughes A, Fremes SE, Youn S, Hancock-Howard RL, Coyte PC, Wijeysundera HC.

J Thorac Cardiovasc Surg. 2018 May;155(5):1978-1988.e1. doi: 10.1016/j.jtcvs.2017.11.112. Epub 2018 Feb 2.

PMID:
29454487
38.

Impact of anticoagulation therapy on valve haemodynamic deterioration following transcatheter aortic valve replacement.

Del Trigo M, Muñoz-García AJ, Latib A, Auffret V, Wijeysundera HC, Nombela-Franco L, Gutierrez E, Cheema AN, Serra V, Amat-Santos IJ, Kefer J, Benitez LM, Leclercq F, Mangieri A, Le Breton H, Jiménez-Quevedo P, Garcia Del Blanco B, Dager A, Abdul-Jawad Altisent O, Puri R, Pibarot P, Rodés-Cabau J.

Heart. 2018 May;104(10):814-820. doi: 10.1136/heartjnl-2017-312514. Epub 2018 Feb 13.

PMID:
29440192
39.

Effect of Electrophysiology Assessment on Mortality and Hospitalizations in Patients With New-Onset Atrial Fibrillation.

Singh SM, Webster L, Qiu F, Austin PC, Ko DT, Tu JV, Wijeysundera HC.

Am J Cardiol. 2018 Apr 1;121(7):830-835. doi: 10.1016/j.amjcard.2017.12.031. Epub 2018 Jan 9.

PMID:
29397105
40.

Standardized Definition of Structural Valve Degeneration for Surgical and Transcatheter Bioprosthetic Aortic Valves.

Dvir D, Bourguignon T, Otto CM, Hahn RT, Rosenhek R, Webb JG, Treede H, Sarano ME, Feldman T, Wijeysundera HC, Topilsky Y, Aupart M, Reardon MJ, Mackensen GB, Szeto WY, Kornowski R, Gammie JS, Yoganathan AP, Arbel Y, Borger MA, Simonato M, Reisman M, Makkar RR, Abizaid A, McCabe JM, Dahle G, Aldea GS, Leipsic J, Pibarot P, Moat NE, Mack MJ, Kappetein AP, Leon MB; VIVID (Valve in Valve International Data) Investigators.

Circulation. 2018 Jan 23;137(4):388-399. doi: 10.1161/CIRCULATIONAHA.117.030729. Review.

PMID:
29358344
41.

Association of high-density lipoprotein cholesterol with non-fatal cardiac and non-cardiac events: a CANHEART substudy.

Wijeysundera HC, Koh M, Alter DA, Austin PC, Jackevicius CA, Tu JV, Ko DT.

Open Heart. 2017 Dec 17;4(2):e000731. doi: 10.1136/openhrt-2017-000731. eCollection 2017.

42.

Gender Differences in Utilization of Specialized Heart Failure Clinics.

Abrahamyan L, Sahakyan Y, Wijeysundera HC, Krahn M, Rac VE.

J Womens Health (Larchmt). 2018 May;27(5):623-629. doi: 10.1089/jwh.2017.6461. Epub 2018 Jan 10.

PMID:
29319404
43.

Cost-Effectiveness of Different Durations of Dual-Antiplatelet Use After Percutaneous Coronary Intervention.

Arbel Y, Bennell MC, Goodman SG, Wijeysundera HC.

Can J Cardiol. 2018 Jan;34(1):31-37. doi: 10.1016/j.cjca.2017.10.004. Epub 2017 Oct 6.

PMID:
29275879
44.

Coronary Chronic Total Occlusions: Time to Abandon a Culture of Therapeutic Nihilism?

Elbaz-Greener G, Wijeysundera HC.

Circ Cardiovasc Qual Outcomes. 2017 Dec;10(12). pii: e004295. doi: 10.1161/CIRCOUTCOMES.117.004295. No abstract available.

PMID:
29237747
45.

Transcatheter Aortic Valve Replacement in Pure Native Aortic Valve Regurgitation.

Yoon SH, Schmidt T, Bleiziffer S, Schofer N, Fiorina C, Munoz-Garcia AJ, Yzeiraj E, Amat-Santos IJ, Tchetche D, Jung C, Fujita B, Mangieri A, Deutsch MA, Ubben T, Deuschl F, Kuwata S, De Biase C, Williams T, Dhoble A, Kim WK, Ferrari E, Barbanti M, Vollema EM, Miceli A, Giannini C, Attizzani GF, Kong WKF, Gutierrez-Ibanes E, Jimenez Diaz VA, Wijeysundera HC, Kaneko H, Chakravarty T, Makar M, Sievert H, Hengstenberg C, Prendergast BD, Vincent F, Abdel-Wahab M, Nombela-Franco L, Silaschi M, Tarantini G, Butter C, Ensminger SM, Hildick-Smith D, Petronio AS, Yin WH, De Marco F, Testa L, Van Mieghem NM, Whisenant BK, Kuck KH, Colombo A, Kar S, Moris C, Delgado V, Maisano F, Nietlispach F, Mack MJ, Schofer J, Schaefer U, Bax JJ, Frerker C, Latib A, Makkar RR.

J Am Coll Cardiol. 2017 Dec 5;70(22):2752-2763. doi: 10.1016/j.jacc.2017.10.006.

46.

The Relationship Between Cardiologist Care and Clinical Outcomes in Patients With New-Onset Atrial Fibrillation.

Singh SM, Qiu F, Webster L, Austin PC, Ko DT, Tu JV, Wijeysundera HC.

Can J Cardiol. 2017 Dec;33(12):1693-1700. doi: 10.1016/j.cjca.2017.10.003.

PMID:
29173608
47.

Cognitive Outcomes After Transcatheter Aortic Valve Implantation: A Metaanalysis.

Khan MM, Herrmann N, Gallagher D, Gandell D, Fremes SE, Wijeysundera HC, Radhakrishnan S, Sun YR, Lanctôt KL.

J Am Geriatr Soc. 2018 Feb;66(2):254-262. doi: 10.1111/jgs.15123. Epub 2017 Nov 21. Review.

PMID:
29159840
48.

Variations in Use of Optimal Medical Therapy in Patients With Nonobstructive Coronary Artery Disease: A Population-Based Study.

Oxner A, Elbaz-Greener G, Qui F, Masih S, Zivkovic N, Alnasser S, Cheema AN, Wijeysundera HC.

J Am Heart Assoc. 2017 Nov 18;6(11). pii: e007526. doi: 10.1161/JAHA.117.007526.

49.

Timing of Conduction Abnormalities Leading to Permanent Pacemaker Insertion After Transcatheter Aortic Valve Implantation-A Single-Centre Review.

Ozier D, Zivkovic N, Elbaz-Greener G, Singh SM, Wijeysundera HC.

Can J Cardiol. 2017 Dec;33(12):1660-1667. doi: 10.1016/j.cjca.2017.08.012. Epub 2017 Sep 1.

PMID:
29102453
50.

Economic Impact of Subsequent Depression in Patients With a New Diagnosis of Stable Angina: A Population-Based Study.

Szpakowski N, Qiu F, Masih S, Kurdyak P, Wijeysundera HC.

J Am Heart Assoc. 2017 Oct 11;6(10). pii: e006911. doi: 10.1161/JAHA.117.006911.

Supplemental Content

Loading ...
Support Center